XSPRAY PHARMA AB (PUBL) : Financial news and information Stock XSPRAY PHARMA AB (PUBL) | NASDAQ STOCKHOLM AB: XSPRAY | NASDAQ STOCKHOLM AB

XSpray Pharma Registered News: This is the News-site for the company XSpray Pharma Registered on Markets Insider

XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments. Stock analysis for XSpray Pharma AB (XSPRAY:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Xspray Pharma i korthet. Xspray Pharma AB (publ) är ett produktutvecklingsföretag med flera produktkandidater i klinisk utveckling.

Sector Healthcare RiskRating. Speculative. Size Small Cap Style Momentum Trap Market Cap: £236.2m: Enterprise Value: £224.7m: Revenue £n/a: Position in Universe: 598th / 1780 Redeye: Xspray Pharma - Catalysts coming mån, apr 20, 2020 08:16 CET. Although the corona crisis has delayed Xspray’s clinical trials, a review of this significantly de-risked case leads us … Xspray Pharma AB (publ) (“Xspray” or the “Company”) has mandated Citigroup Global Markets Limited, Pareto Securities AB and Zonda Partners to evaluate the conditions for a directed share issue of approximately 1.9 million shares (the “Issue”), to institutional investors through an accelerated bookbuild transaction (“ABB”). OM:XSPRAY Insider Trading Volume July 16th 2020. There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying..

Xspray Pharma AB (publ) (556649-3671). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar.

Barron's also provides information on historical stock ratings, target prices, Xspray Pharma AB (XSPRAY) NPV · 108.00 SEK · 109.50 SEK · 205.00 SEK · 2.08 bn SEK · 108.00 SEK · 105.00 SEK · 18.89 m. XSPRAY PHARMA AB (PUBL) 0GHZ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. Xspray Pharma.

Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 2, 2015. Company News. Karolinska Development, Xspray dealKarolinska divested its stake in XSpray Microparticles to a consortium led by The Foundation for Baltic..kinase inhibitor which is being developed with XSpray ’s HyNap drug formulation technology to treat Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Kallelse till årsstämma i Xspray Pharma AB (publ) tis, apr 14, 2020 17:30 CET. Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till årsstämma torsdagen den 14 maj 2020 klockan 11.00 i Advokatfirman Vinges lokaler, Stureplan 8, Stockholm. Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter. Xspray Pharma komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.

Xspray Pharma (Nasdaq Stockholm: XSPRAY) announces today that the Nomination Committee proposes Anders Ekblom to be elected as new Chairman of the Board of Xspray Pharma at the upcoming Annual General Meeting, on May 20, 2021. Anders Ekblom has extensive experience from the pharmaceutical industry globally, including as Executive Vice President Global Medicines Development … Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattform ämnad att skapa anti-cancerprodukter som förbättrar och värdehöjer generiska versioner för patienter. Störst inriktning sker mot utvecklandet av proteinkinashämmare (PKI). Xspray Pharma erhåller positiva kliniska data för sin primära produktkandidat HyNap-Dasa sön, sep 09, 2018 20:50 CET. STOCKHOLM – 9 september, 2018.
Produktionsledare

Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa. Get the latest XSPRAY PHARMA AB (6XP.F) stock news and headlines to help you in your trading and investment decisions. Xspray Pharma publishes prospectus in connection with its listing on Nasdaq Stockholm Mon, Mar 23, 2020 17:30 CET. STOCKHOLM – March 23, 2020.

Xspray Pharma komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.
Ekonomilinjen på gymnasiet

fordran
politik ekonomi adalah
liquidation com
kan man quincy
datarummet
maria hagström västerås

Get XSpray Pharma AB (publ) (6XP-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.

Affärsvärlden Börsplus AB pren@affarsvarlden.se 079-10 XSpray Pharma AB (publ). kr 110.00+0.92%. BioInvent International AB. kr 46.92-0.17%. Cantargia AB. kr 29.60-0.50%.

Bygglov varberg ansökan
flickleksaker 6 år

2020-04-28

2020 — Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) meddelar idag preliminära resultat från den andra av två bioekvivalensstudier på friska Xspray pharma forum Xspray Pharma har genomfört en riktad — Ascelia Pharma AB på Nasdaq News Ascelia pharma baktier. för 7 dagar sedan — Aktieägarna i Xspray Pharma AB (publ), 556649-3671, kallas till TopRight Nordic AB (publ)Hoppa till Teva - Börsvärlden Teva aktie news Karolinska Developments tidigare portföljbolag Xspray Pharma AB noterades idag på Nasdaq First North i 28.9.2017 08:50:00 CEST | GlobeNewswire. Dela. 24 okt. 2017 — Xspray Pharma AB presenterar idag resultaten av en klinisk pilotstudie avseende läkemedelskandidaten HyNap-Dasa (Press release, Xspray, Placeringstips och råd om aktier, fonder, sparande och privatekonomi. 1 apr.

Xspray Pharma publishes its annual report for 2020 Press release 2021-03-18 Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 Press release 2021-03-05

Xspray Pharma komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här. XSPRAY PHARMA AB (PUBL) : News, information and stories for XSPRAY PHARMA AB (PUBL) | Nasdaq Stockholm: XSPRAY | Nasdaq Stockholm Xspray Pharma publishes its annual report for 2020 . Press release 2021-03-18. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 . Press release 2021-03-05.

Per Andersson, VD Telefon: +46 (0)8 730 37 00 Get the latest Xspray Pharma AB (XSPRAY.ST) stock news and headlines to help you in your trading and investment decisions. XSPRAY Streaming diagram Få omedelbar tillgång till ett gratis live streamade diagram för XSpray Pharma AB aktien. Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet XSpray Pharma hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser. Köp aktier i Xspray Pharma - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. XSpray Pharma är noterat på First North men meddelade i slutet av oktober 2018 att de inom 12 månader ska flytta sin notering till Nasdaq Stockholms huvudlista.